Consensus $4.64. Mendelsohn continued, “The balance sheet continues to be in great shape and strategically positions NHI to execute on the acquisition opportunity in a very active senior housing pipeline. We have already announced investments of $174.9 million year-to-date at an average initial yield of 8.2% and we are evaluating a pipeline of approximately $264.0 million, including SHOP deals. We are also making progress on internal SHOP conversions which we expect to increase our organic growth profile.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors Releases Investor Update Presentation
- National Health Investors Releases Q1 2025 Financial Update
- National Health Investors reports Egan-Jones recommendation for white proxy card
- Is NHI a Buy, Before Earnings?
- National Health Investors price target lowered to $83 from $91 at BofA